MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan

Phase 4
Completed
Conditions
Malaria
Interventions
Drug: ASP
Drug: SDPQ
Drug: 14DPQ on Day 42
Drug: 14DPQ
First Posted Date
2015-10-30
Last Posted Date
2017-02-01
Lead Sponsor
Menzies School of Health Research
Target Recruit Count
320
Registration Number
NCT02592408
Locations
🇸🇩

New Halfa Hospital, New Halfa, Kassalla, Sudan

🇸🇩

Gizeria Slang Hospital, Khartoum, Sudan

© Copyright 2025. All Rights Reserved by MedPath